Exosomes derived from umbilical cord mesenchymal stem cells alleviate jaw bone marrow mesenchymal stem cells senescence and restore osteogenic differentiation potential.
Abstract
The age-related functional decline of bone marrow mesenchymal stem cells significantly impairs bone regeneration capacity. Exosomes derived from umbilical cord mesenchymal stem cells (UCMSCs) have emerged as promising therapeutic agents in regenerative medicine and anti-aging research due to their bioactive cargo and low immunogenicity. This study investigated the rejuvenating potential of UCMSCs-derived exosomes (UCMSC-Exos) on senescent jaw bone marrow mesenchymal stem cells (JBMMSCs) and their ability to enhance bone repair in aged rats.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
Exosomes derived from umbilical cord mesenchymal stem cells can rejuvenate senescent jaw bone marrow mesenchymal stem cells and enhance their osteogenic differentiation. This research addresses the functional decline of stem cells associated with aging, which is a root cause of age-related degeneration and has implications for regenerative medicine in the context of longevity.
Author of this paper? Send a correction.